Abbott India informs about change in directorate

13 Mar 2024 Evaluate
Pursuant to Regulation 30 read with Clause 7 of Para A of Part A of Schedule Ill of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Abbott India has informed that, upon recommendation of the Nomination and Remuneration Committee and subject to the approval of the Shareholders, the Board of Directors at its Meeting held today i.e., March 13, 2024: a) Approved the appointment of Swati Dalal (DIN: 01513751) as an Additional Director of the Company with effect from April 1, 2024. b) Approved the appointment of Swati Dalal (DIN: 01513751) as the Managing Director of the Company for a period of 3 (three) years with effect from April 1, 2024. On her appointment as Managing Director, Swati Dalal shall also be the Key Managerial Personnel of the Company effective the same date. c) Approved the Postal Ballot Notice to seek approval of the Shareholders for the abovementioned appointment(s). The Postal Ballot Notice shall be sent to the Shareholders in due course and the same shall be filed with the Stock Exchange. Details pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 and BSE Circular No. LIST/COMP/14/2018-19 dated June 20, 2018, is enclosed as Annexure A.

The above information is a part of company’s filings submitted to BSE.

Abbott India Share Price

26617.85 127.65 (0.48%)
18-May-2024 12:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.85
Dr. Reddys Lab 5812.50
Cipla 1403.90
Zydus Lifesciences 1104.45
Lupin 1661.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.